With our products, we aim to revolutionize medical shockwave therapy while improving patient outcomes. Our most advanced applicator is the first shockwave device for direct cardiac application during Coronary Artery Bypass Grafting (CABG) surgery in the world. It features advanced technology that allows for precise and deep shockwave application. The handling is intuitive and simple, giving therapists full control over the treatment.
Regeneration of infarcted heart muscle remained an unsolved clinical problem despite decades of research on (stem) cell and gene therapy.
Shockwave therapy induces tissue regeneration in infarcted heart muscle and thereby significantly improves heart function (left ventricular ejection fraction). Shockwave therapy is proven safe in millions of patients over more than 35 years in orthopedic indications. This distinguishes shockwave therapy clearly from all other regenerative therapy approaches.
The main achievement of Avenns Medical is to refine low-energy regenerative shockwave therapy for direct cardiac use. We developed a sterile applicator suitable for direct cardiac application during heart surgery.
Shockwaves at low energy levels exert regenerative effects rather than disintegration of stones or plaques such as with high energies in Lithotripsie.
Numerous small and large animal trials of our academic research partners helped us to elucidate the exact molecular working mechanism of the new technology. Safety and feasibility have been proven in a human pilot trial. The efficacy has already been proven at the Medical University of Innsbruck in a prospective randomized-controlled trial, with results surpassing expectations.
Research results of our academic partners have been published in high-ranked scientific journals (e.g. Cardiovascular Research, JAHA, JTCVS, PLoS One) and presented at major international meetings (e.g. ESC, AHA, EACTS).
Investing in our company is an opportunity to support cutting-edge technology in the medical field. We have developed a shockwave device for heart muscle regeneration that is unparalleled globally. Our device has the potential to revolutionize the way heart conditions are treated and improve the quality of life for millions of patients worldwide.
Our team consists of experienced professionals with a proven track record of success. We have invested heavily in research and development to create a product that is not only unique but also highly effective. Our device has undergone extensive testing and has received positive feedback from both healthcare providers and patients.
Investing in our company offers a chance to be a part of a growing and innovative industry. The market for medical devices, especially those related to heart health, is expected to continue to grow in the coming years. By investing in our company, you have the opportunity to capitalize on this growth and potentially reap significant returns on your investment.
In addition to financial benefits, investing in our company allows you to make a positive impact on society. Our mission is to improve the lives of patients with heart failure and we are committed to advancing this cause through our innovative technology.